关于天演：
天演药业（纳斯达克股票代码：ADAG）是一家平台驱动并拥有自主平台产出的临床产品开发阶段的生物制药公司，公司致力于发现并开发以原创抗体为基石的新型癌症免疫 疗法。借力于计算生物学与人工智能，天演药业已建立起聚焦于新型肿瘤免疫疗法的独特原创的抗体产品线，以解决尚未满足的临床需求。天演已和多个全球知名合作伙伴达成了战略合作关系，并以其多种原创前沿科技为合作伙伴的新药研发赋能。
Adagene is a private, global, clinical-stage immunotherapy company redefining the discovery and design of antibodies to open new horizons in the treatment of cancer.
Driven by a powerful platform combining computational biology and artificial intelligence, we create novel antibodies that overcome safety issues and improve efficacy to bring hope to more cancer patients. Our discovery engine, Dynamic Precision Library, is driving Adagene’s pipeline of programs with potential to be first or best in class.
We have forged strategic partnerships with multiple reputable global companies. These partnerships leverage our technology in approaches at the vanguard of science, including safer precision-guided antibody-drug conjugates, transformative antibody design and advanced CAR constructs for significant unmet needs.
Founded and led by world-class leaders in antibody discovery and engineering, we have raised more than $150 million from high-profile investors. Adagene is wellpositioned to address unmet needs in areas where other treatments have had little or
no success.
联系方式：
公司地址：苏州工业园区星湖街 218 号 C14 幢 3-4 楼
公司网址：https://www.adagene.com/
简历投递：hr@adagene.com.cn